BOTME Study: A National e‐Delphi Study on the Use of Botulinum Toxin for Aesthetic Treatment of Middle Easterners
Journal of Cosmetic Dermatology · 2025
DOI: 10.1111/jocd.70492 ↗Kurz gefasst
Delphi-Studie in der Zeitschrift Journal of Cosmetic Dermatology, 2025. Verfasst von Mohammed Al-Haddab und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, College of Medicine, King Saud University, Riyadh, Saudi Arabia. Hauptthemen laut MEDLINE: Botulinum Toxins, Type A, Cosmetic Techniques, Skin Aging, Neuromuscular Agents. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
The demand for botulinum toxin A (BTX‐A) cosmetic treatments is growing among individuals with skin of color, primarily due to increased cultural acceptance, social media influence, and patient awareness. However, there remains a lack of standardized, evidence‐based guidance on the use of BTX‐A in these populations.
Objective
To develop consensus‐based clinical recommendations on aesthetic botulinum toxin injection practices in patients with skin of color.
Methods
A modified e‐Delphi method was conducted with 10 board‐certified dermatologists specializing in cosmetic dermatology. Inclusion criteria required ≥ 5 years of experience and publications, or teaching activity in BTX‐A use. Two e‐Delphi rounds evaluated 29 evidence‐based statements. Consensus was defined as ≥ 70% agreement.
Results
Consensus was achieved on 22 statements. Key recommendations included initiating BTX‐A treatments at ages 30–35, dosing 40–60 IU for the upper face, with 16–20 week intervals, using 2 mL of saline reconstitution per 100 IU, and employing 30‐gauge insulin syringes. Topical EMLA was collectively agreed upon for pain control. While several technical aspects, such as injection depth and under‐eye applications, remained inconclusive, participants decided on key practical precautions, including posttreatment activity restrictions.
Conclusion
These consensus‐based recommendations can standardize, make BTX‐A injections safe and effective for skin of color patients, supporting more uniform and comparable treatment results.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
- Department of Dermatology, Prince Sultan Medical Military City, Riyadh, Saudi Arabia.
- Department of Dermatology, College of Medicine, Prince Sattam Bin Abdulaziz University, Al-Kharj, Saudi Arabia.
- Department of Dermatology, King Faisal Hospital, Makkah, Saudi Arabia.
- Department of Dermatology, Aliman General Hospital, Riyadh, Saudi Arabia.
ORCID-Profile: Fatimah J Al Muqarrab
Zitieren
APA
Al-Haddab, M., AlFada, M., Alqubaisy, Y., Alshahrani, N., Alsufyani, M. A., Madani, A., Aleisa, A., Alotaibi, H. O., Alajlan, A., Alsubait, N., & Al Muqarrab, F. J. (2025). BOTME Study: A National e‐Delphi Study on the Use of Botulinum Toxin for Aesthetic Treatment of Middle Easterners. Journal of Cosmetic Dermatology. https://doi.org/10.1111/jocd.70492
Vancouver
Al-Haddab M, AlFada M, Alqubaisy Y, Alshahrani N, Alsufyani MA, Madani A, et al. BOTME Study: A National e‐Delphi Study on the Use of Botulinum Toxin for Aesthetic Treatment of Middle Easterners. Journal of Cosmetic Dermatology. 2025. doi:10.1111/jocd.70492
BibTeX
@article{AlHaddab2025,
author = {Al-Haddab, Mohammed and AlFada, Mohammed and Alqubaisy, Yasser and Alshahrani, Naif and Alsufyani, Mohammed A and Madani, Abdulaziz and Aleisa, Abdullah and Alotaibi, Homaid Obidullah and Alajlan, Abdulmajeed and Alsubait, Norah and Al Muqarrab, Fatimah J},
title = {BOTME Study: A National e‐Delphi Study on the Use of Botulinum Toxin for Aesthetic Treatment of Middle Easterners},
journal = {Journal of Cosmetic Dermatology},
year = {2025},
doi = {10.1111/jocd.70492}
}
EUVIMED